Publications by authors named "A Dane"
Article Synopsis
- Nasal carriers were split into two groups to receive either XF-73 nasal gel or a placebo, administered five times over approximately 24 hours before cardiac surgery.
- Patients using XF-73 showed a significant reduction in bacteria levels after two doses, with a decrease of -2.2 log CFU/mL, while the placebo group had almost no reduction at -0.01 log CFU/mL.
- Post-surgery, 46.5% of the XF-73 group required anti-staphylococcal antibiotics compared to 70% in the placebo group, indicating a significant reduction in post-operative antibiotic usage for those treated with XF-73 (p = 0.045).
Reproducibility of computational research is often challenging despite established guidelines and best practices. Translating these guidelines into practical applications remains difficult. Here, we present ENCORE, an approach to enhance transparency and reproducibility by guiding researchers in how to structure and document a computational project.
View Article and Find Full Text PDFHealth authorities use value-based pricing models to determine the value of innovative drugs and to establish a price. Pharmaceutical companies prefer value-based pricing over cost-based pricing. It is ambiguous whether value-based pricing has the same meaning to these stakeholders.
View Article and Find Full Text PDF